- FDA’s Thoughts on Adolescents in Adult Clinical Oncology Trials
- FDA releases Q&A Guidance After Confusion Surrounding S9A Nonclinical Evaluation for Anticancer Pharmaceuticals Guidance
- BsUFA II fees—are you aware of the major changes?
- FDA Public Docket for Technical Specifications
- Update to the eCTD “Mandate”